Antibiotic impurity standards
Antibiotic impurities and related substances, used to identify and quantify the species that appear in a related-substances or stability-indicating method. Each item is documented lot by lot so that the analytical value used in a calculation can be traced back to a certificate.
66 items in this group. Every one has its own page with the CAS number, molecular data, available pack sizes and the documentation on file; the batch certificate of analysis states the value assigned to the lot you receive.
Impurities in fermentation-derived products
Antibiotics produced by fermentation bring a wider impurity profile than a fully synthetic route: related substances from the producing organism, degradants from a labile functional group, and isomers that differ only in stereochemistry. The reference standards for these are frequently not commercially available and have to be isolated or synthesised.
Why the isomer detail matters
Many antibiotic impurity pairs are structural isomers that elute close together. Resolving them is a method property, but identifying them is a standards property: an assignment is only usable if the material behind it was characterised spectroscopically and can be compared with the peak in the sample.
Documentation
Each item carries a certificate of analysis for the lot with the assigned content and the method used, plus storage and shipping conditions appropriate to the compound. Where the material is isolated from a batch, the isolation is recorded and the assignment is supported by the analytical evidence.
Frequently asked questions
Do you hold pharmacopoeial antibiotic impurities?
Yes — EP and USP named impurities across the antibiotic groups, with CAS number and lot certificate.
Can you isolate an impurity from a batch we supply?
Isolation and purification is done as project work; send the batch information and the target impurity, and feasibility is confirmed before quoting.
How is identity established for a novel impurity?
By spectroscopy (NMR and HRMS) against the proposed structure, and by comparison with the peak in the sample. Retention time alone is not identification.
| Product | CAS | Cat. no. | Status |
|---|---|---|---|
| Azithromycin EP Impurity C | 620169-47-3 | C4X-10036 | In stock |
| Azithromycin EP Impurity D | 612069-26-8 | C4X-100324 | In stock |
| Azithromycin EP Impurity O | 763924-54-5 | C4X-100320 | In stock |
| Clindamycin Phosphas EP Impurity L | 620181-05-7 | C4X-134110 | In stock |
| Fosfomycin Trometamol EP Impurity D | 1262243-12-8 | C4X-13165 | On synthesis |
| Cefquinome | 84957-30-2 | CCAD301155 | On synthesis |
| Roxithromycin EP Impurity G | 425365-64-6 | C4X-13037 | In stock |
| Vancomycin EP Impurity F | 2415254-43-0 | C4X-17757 | In stock |
| Clarithromycin EP Impurity B | 299409-85-1 | C4X-100218 | In stock |
| Roxithromycin EP Impurity H | 425365-65-7 | C4X-13038 | In stock |
| Vancomycin EP Impurity H | 357396-41-9 | C4X-177515 | In stock |
| Desfuroyl Ceftiofur | 120882-22-6 | CCAD300713 | In stock |
| Erythromycin EP Impurity K | 33442-56-7 | C4X-100143 | On synthesis |
| Gentamicin C1 | 25876-10-2 | C1825027 | On synthesis |
| Omacycline 7-desmethyl impurity | 2272886-38-9 | C4X-28574 | In stock |
| Roxithromycin EP Impurity E | 1460313-66-9 | C4X-13035 | On synthesis |
| Vancomycin EP Impurity I | — | C4X-177510 | In stock |
| Vancomycin EP Impurity J | 2416251-24-4 | C4X-177511 | On synthesis |
| Vancomycin EP Impurity K | 99759-13-4 | C4X-177518 | In stock |
| Vancomycin EP Impurity L | 79517-31-0 | C4X-177513 | In stock |
| Azithromycin EP Impurity K | 612534-95-9 | C4X-100311 | In stock |
| Clarithromycin EP Impurity A | 124412-58-4 | C4X-100213 | In stock |
| Fosfomycin Impurity 24 | 1416734-33-2 | C4X-131624 | On synthesis |
| Vancomycin EP Impurity G | — | C4X-17758 | In stock |
| Minocycline | 10118-90-8 | CCAD304335 | On synthesis |
| Cefcapene Impurity 12 | 3025716-46-2 | C4X-182412 | On synthesis |
| Clarithromycin EP Impurity F | 128940-83-0 | C4X-100211 | On synthesis |
| Imipenem EP Impurity A | 59995-64-1 | C4X-16621 | On synthesis |
| Roxithromycin EP Impurity K | — | C4X-130312 | In stock |
| 3-N-Ureido Tobramycin | — | C4X-220011 | On synthesis |
| Clarithromycin EP Impurity P | 123967-58-8 | C4X-100215 | In stock |
| Erythromycin EP Impurity N | 3225-82-9 | C4X-100142 | On synthesis |
| Minocycline Impurity 33 | — | C4X-169933 | On synthesis |
| Moxifloxacin Impurity RC-4 | 2928577-05-1 | C4X-107459 | On synthesis |
| Neomycin EP Impurity C | 66-86-4 | C4X-18453 | On synthesis |
| Oleandomycin | 3922-90-5 | CCAD301415 | On synthesis |
| 16-(Hydroxymethyl) Rifampicin | — | C4X-145613 | On synthesis |
| Clindamycin B Palmitate | 68206-99-5 | C1798828 | On synthesis |
| Gentamicin Impurity 12 | 25876-11-3 | C4X-148012 | On synthesis |
| Pirlimycin Hydrochloride | 78822-40-9 | CCAD301503 | On synthesis |
| (5aR)-7-Desdimethylamino-7-((2-(dimethylamino)ethyl)(methyl))amino)-Minocycline | — | C4X-169936 | In stock |
| Cefaclor Impurity 33 | 188915-45-9 | C4X-127033 | In stock |
| Cefcapene Impurity 24 | — | C4X-182424 | On synthesis |
| Clindamycin (2R-cis)-Diastereomer 2-Phosphate | 1800297-62-4 | C4X-134139 | On synthesis |
| Eravacycline Impurity 12 (TP-5799) | — | C4X-293812 | On synthesis |
| Eravacycline Impurity 9 (TP-4705) | — | C4X-29389 | On synthesis |
| Fosfomycin Impurity 58 | — | C4X-131658 | On synthesis |
| Fosfomycin Impurity 72 | 26017-01-6 | C4X-131672 | On synthesis |
| Omacycline Impurity 6 | 1075240-42-4 | C4X-28576 | On synthesis |
| 7-Ethyl Methyl Amino Minocycline | 32598-29-1 | C4X-169928 | On synthesis |
| Cefaclor EP Impurity G-Isomer 1 | 67308-21-8 | C4X-12707 | In stock |
| Clindamycin Isomer Impurity (Clindamycin EP Impurity F) | 1440605-46-8 | C4X-13416 | In stock |
| Eravacycline Impurity 3 (TP-9944) | — | C4X-29383 | On synthesis |
| Eravacycline Impurity 4 (TP-4308) | — | C4X-29384 | On synthesis |
| Eravacycline Impurity 7 (TP-498) | — | C4X-29387 | On synthesis |
| Erythromycin EP Impurity M | 616234-56-1 | C4X-100144 | On synthesis |
| Tobramycin-D, 18O Acetic Acid Salt | — | CCAD302249 | On synthesis |
| Cefpodoxime Proxetil EP Impurity H | 947692-16-2 | C4X-157913 | On synthesis |
| Cefuroxime sodium GSK ring opening impurity | — | C4X-124528 | On synthesis |
| Eravacycline Impurity 2 (TP-2905) | — | C4X-29382 | On synthesis |
| Eravacycline Impurity 5 (TP-6773) | — | C4X-29385 | On synthesis |
| Fosfomycin Impurity 42 | 45629-00-3 | C4X-131642 | On synthesis |
| Fosfomycin Impurity 54 | 438210-39-0 | C4X-131654 | On synthesis |
| Methacycline | 914-00-1 | CCAD302071 | On synthesis |
| Neomycin EP Impurity B | 54617-39-9 | C4X-18458 | On synthesis |
| Omacycline M+2 impurity | 2272886-40-3 | C4X-285726 | On synthesis |
Request a quote or email chao.lu@cato-chem.com
Other groups: Impurity and metabolite reference standards · Mycotoxin reference standards · Nitrosamine and nitrosamine-impurity standards · PFAS reference standards · Pesticide and veterinary drug reference standards · Pharmacopoeial impurity standards · Solution and multi-component standards · Stable isotope labelled internal standards · Vitamin reference standards







